Mochida Pharmaceutical Co., Ltd. (4534.T)
JPY 3140.0
(2.11%)
JPY 3140.0
(2.11%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 4.54 Billion JPY | -31.61% |
| 2022 | 6.64 Billion JPY | -37.09% |
| 2021 | 10.56 Billion JPY | 23.08% |
| 2020 | 8.58 Billion JPY | 86.76% |
| 2019 | 4.59 Billion JPY | -45.49% |
| 2018 | 8.43 Billion JPY | -6.52% |
| 2017 | 9.02 Billion JPY | 5.83% |
| 2016 | 8.52 Billion JPY | 4.61% |
| 2015 | 8.15 Billion JPY | 8.03% |
| 2014 | 7.54 Billion JPY | -23.74% |
| 2013 | 9.89 Billion JPY | 8.09% |
| 2012 | 9.15 Billion JPY | 0.84% |
| 2011 | 9.07 Billion JPY | 70.19% |
| 2010 | 5.33 Billion JPY | -45.96% |
| 2009 | 9.86 Billion JPY | 12.74% |
| 2008 | 8.75 Billion JPY | 4.38% |
| 2007 | 8.38 Billion JPY | 39.09% |
| 2006 | 6.03 Billion JPY | 20.89% |
| 2005 | 4.98 Billion JPY | 116.96% |
| 2004 | 2.29 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 1.55 Billion JPY | 1408.74% |
| 2024 Q2 | 1.27 Billion JPY | -18.21% |
| 2023 FY | 4.54 Billion JPY | -31.61% |
| 2023 Q4 | 103 Million JPY | -93.59% |
| 2023 Q3 | 1.6 Billion JPY | 39.65% |
| 2023 Q1 | 1.68 Billion JPY | 217.88% |
| 2023 Q2 | 1.15 Billion JPY | -31.87% |
| 2022 Q1 | 3.15 Billion JPY | 711.05% |
| 2022 Q4 | -1.43 Billion JPY | -134.44% |
| 2022 Q3 | 4.15 Billion JPY | 441.41% |
| 2022 Q2 | 768 Million JPY | -75.66% |
| 2022 FY | 6.64 Billion JPY | -37.09% |
| 2021 Q4 | 389 Million JPY | -92.61% |
| 2021 Q1 | 2.65 Billion JPY | 1373.89% |
| 2021 FY | 10.56 Billion JPY | 23.08% |
| 2021 Q2 | 2.26 Billion JPY | -14.7% |
| 2021 Q3 | 5.26 Billion JPY | 132.61% |
| 2020 Q2 | 2.04 Billion JPY | -39.29% |
| 2020 FY | 8.58 Billion JPY | 86.76% |
| 2020 Q1 | 3.36 Billion JPY | 289.16% |
| 2020 Q4 | 180 Million JPY | -93.99% |
| 2020 Q3 | 2.99 Billion JPY | 46.58% |
| 2019 Q2 | 1.28 Billion JPY | -61.06% |
| 2019 Q1 | 3.3 Billion JPY | 333.73% |
| 2019 FY | 4.59 Billion JPY | -45.49% |
| 2019 Q4 | -1.78 Billion JPY | -199.66% |
| 2019 Q3 | 1.78 Billion JPY | 38.77% |
| 2018 FY | 8.43 Billion JPY | -6.52% |
| 2018 Q2 | 1.09 Billion JPY | -81.29% |
| 2018 Q3 | 2.91 Billion JPY | 166.51% |
| 2018 Q4 | -1.41 Billion JPY | -148.54% |
| 2018 Q1 | 5.84 Billion JPY | 2465.59% |
| 2017 Q4 | -247 Million JPY | -107.38% |
| 2017 Q3 | 3.34 Billion JPY | 108.73% |
| 2017 Q1 | 4.31 Billion JPY | 440.27% |
| 2017 FY | 9.02 Billion JPY | 5.83% |
| 2017 Q2 | 1.6 Billion JPY | -62.85% |
| 2016 Q2 | 2.28 Billion JPY | -30.17% |
| 2016 Q4 | -1.26 Billion JPY | -129.98% |
| 2016 Q3 | 4.23 Billion JPY | 85.09% |
| 2016 FY | 8.52 Billion JPY | 4.61% |
| 2016 Q1 | 3.27 Billion JPY | 1420.56% |
| 2015 FY | 8.15 Billion JPY | 8.03% |
| 2015 Q4 | -248 Million JPY | -106.92% |
| 2015 Q3 | 3.58 Billion JPY | 121.72% |
| 2015 Q2 | 1.61 Billion JPY | -49.48% |
| 2015 Q1 | 3.19 Billion JPY | 204.38% |
| 2014 Q2 | 1.17 Billion JPY | -38.7% |
| 2014 Q3 | 3.39 Billion JPY | 188.53% |
| 2014 Q4 | 1.05 Billion JPY | -69.05% |
| 2014 FY | 7.54 Billion JPY | -23.74% |
| 2014 Q1 | 1.92 Billion JPY | 38.33% |
| 2013 Q1 | 1.94 Billion JPY | 16.38% |
| 2013 Q3 | 4.1 Billion JPY | 66.4% |
| 2013 Q4 | 1.38 Billion JPY | -66.15% |
| 2013 FY | 9.89 Billion JPY | 8.09% |
| 2013 Q2 | 2.46 Billion JPY | 27.01% |
| 2012 FY | 9.15 Billion JPY | 0.84% |
| 2012 Q3 | 2.33 Billion JPY | -5.85% |
| 2012 Q4 | 1.66 Billion JPY | -28.55% |
| 2012 Q1 | 2.67 Billion JPY | 285.86% |
| 2012 Q2 | 2.47 Billion JPY | -7.33% |
| 2011 Q1 | 272 Million JPY | 120.03% |
| 2011 Q2 | 4.43 Billion JPY | 1529.78% |
| 2011 Q4 | 693 Million JPY | -81.16% |
| 2011 FY | 9.07 Billion JPY | 70.19% |
| 2011 Q3 | 3.67 Billion JPY | -17.03% |
| 2010 Q2 | 1.72 Billion JPY | -20.1% |
| 2010 Q1 | 2.15 Billion JPY | 89.39% |
| 2010 Q3 | 2.8 Billion JPY | 62.67% |
| 2010 Q4 | -1.35 Billion JPY | -148.4% |
| 2010 FY | 5.33 Billion JPY | -45.96% |
| 2009 Q2 | 3.33 Billion JPY | 29.2% |
| 2009 Q4 | 1.14 Billion JPY | -59.43% |
| 2009 Q3 | 2.81 Billion JPY | -15.77% |
| 2009 Q1 | 2.58 Billion JPY | 139.74% |
| 2009 FY | 9.86 Billion JPY | 12.74% |
| 2008 Q4 | 1.07 Billion JPY | -64.64% |
| 2008 Q2 | 2.63 Billion JPY | 0.0% |
| 2008 FY | 8.75 Billion JPY | 4.38% |
| 2008 Q3 | 3.04 Billion JPY | 15.69% |
| 2007 FY | 8.38 Billion JPY | 39.09% |
| 2006 FY | 6.03 Billion JPY | 20.89% |
| 2005 FY | 4.98 Billion JPY | 116.96% |
| 2004 FY | 2.29 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 3.2 Billion JPY | -41.872% |
| Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | 96.844% |
| Sumitomo Pharma Co., Ltd. | -314.96 Billion JPY | 101.444% |
| Shionogi & Co., Ltd. | 162.03 Billion JPY | 97.194% |
| Wakamoto Pharmaceutical Co.,Ltd. | 108.95 Million JPY | -4073.129% |
| Nippon Shinyaku Co., Ltd. | 25.85 Billion JPY | 82.411% |
| Kaken Pharmaceutical Co., Ltd. | 8.02 Billion JPY | 43.34% |
| Eisai Co., Ltd. | 42.4 Billion JPY | 89.278% |
| Morishita Jintan Co., Ltd. | 697 Million JPY | -552.367% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.96 Billion JPY | 67.449% |
| Fuso Pharmaceutical Industries,Ltd. | 1.37 Billion JPY | -230.211% |
| Nippon Chemiphar Co., Ltd. | -180 Million JPY | 2626.111% |
| Tsumura & Co. | 16.7 Billion JPY | 72.784% |
| Kissei Pharmaceutical Co., Ltd. | 11.16 Billion JPY | 59.256% |
| Torii Pharmaceutical Co., Ltd. | 4.11 Billion JPY | -10.391% |
| Towa Pharmaceutical Co., Ltd. | 16.17 Billion JPY | 71.885% |
| Fuji Pharma Co., Ltd. | 3.43 Billion JPY | -32.373% |
| Zeria Pharmaceutical Co., Ltd. | 7.73 Billion JPY | 41.187% |
| KYORIN Holdings, Inc. | 5.32 Billion JPY | 14.562% |
| Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | 192.91% |
| Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | -37.997% |
| SymBio Pharmaceuticals Limited | -1.96 Billion JPY | 331.657% |
| MedRx Co., Ltd | -932 Million JPY | 587.876% |
| Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | -20.475% |
| Solasia Pharma K.K. | -1.11 Billion JPY | 508.903% |
| Modalis Therapeutics Corporation | -2.39 Billion JPY | 290.106% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | 39.735% |
| Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | 66.798% |
| Cyfuse Biomedical K.K. | -589.21 Million JPY | 871.71% |
| Toho Holdings Co., Ltd. | 20.65 Billion JPY | 77.988% |
| Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | -54.327% |